Informa Connect

Informa Connect specializes in live events and digital content, bringing together professionals to share knowledge, ideas, and opportunities.

International

English

Media Company

Outlet metrics

Domain Authority

Ranking

Global

#98341

United States

#38800

Finance/Finance

#597

Traffic sources

Monthly visitors

Articles

Bridging business and ethics: A pharmaceutical compliance leader’s perspective

2 days ago | informaconnect.com | Brandy Fidler

Compliance leadership in pharmaceuticals demands a delicate balance of technical expertise, strategic vision, and ethical stewardship, according to Peter J. Agnoletto, strategic business advisor, General Medicines U.S., at Sanofi. With over two decades of experience in multibillion-dollar international public companies, Agnoletto brings a wealth of knowledge from his roles, including his previous position as chief compliance officer and chief audit executive at Par Pharmaceuticals Companies.
DEI has improved clinical trials according to ACRP survey

2 weeks ago | informaconnect.com | Gareth Macdonald

Data generated in clinical trials has improved over the past decade due, in part, to efforts to include participants from minority and traditionally underrepresented groups. The conclusion comes from an Association of Clinical Research Professionals (ACRP) survey which quizzed CROs, research sites and academics about the trials sector and found, in general, that things are improving.
PAN Foundation report shows concerning trends for patient access

2 weeks ago | informaconnect.com | Brandy Fidler

Amy Niles, the PAN Foundation’s chief mission officer, spoke exclusively with Access Insider about the current state of patient access, the barriers, the value of advocacy, and the need for action.
Lokavant rolls out “causal AI” based study feasibility tool

2 weeks ago | informaconnect.com | Gareth Macdonald

Clinical intelligence firm Lokavant has released an AI-based clinical trial forecasting technology it claims will help sponsors identify the best site and country combinations for their drug study programmes. The system – called Spectrum v15 – uses a combination of AI models trained on a data set of 500,000 trials to predict the probability of achieving key last-patient-in targets.
Novo Nordisk Deepens Obesity Pipeline with Strategic China Bet: Jenny Yang on Building Global Value from Local Innovation

3 weeks ago | informaconnect.com | Brian Yang

Novo Nordisk Deepens Obesity Pipeline with Strategic China Bet: Jenny Yang on Building Global Value from Local InnovationChinaBio® Partnering Forum Thought Leadership SeriesBrian YangNovo Nordisk, the global leader in glucagon-like peptide (GLP)-1-based therapies, is reinforcing its obesity portfolio through a series of targeted partnerships in China, underscoring the country’s emergence as a high-value source of innovation in metabolic disease.
Better collaboration is needed among patient advocacy groups and biotech

3 weeks ago | informaconnect.com | Brandy Fidler

In a recent fireside chat at the Rare Disease Summit in Philadelphia, Karin Hoelzer, senior director, patient advocacy at Biotechnology Innovation Organization (BIO), and Tricha Shivas chief strategy officer at the Foundation for Sarcoidosis Research explored the role patient advocacy groups play in accelerating and improving the development of therapies for rare diseases.
Psyence Biomed hires Southern Star for Phase II psilocybin study

3 weeks ago | informaconnect.com | Gareth Macdonald

Psyence BioMed has hired Southern Star Research to run a clinical trial of the magic mushroom-derivative psilocybin in patients with adjustment disorder. The study — a Phase IIb trial — will examine the drug as a treatment for the psychological condition in people diagnosed with cancer. According to a recently published letter of intent, Sydney, Australia-based contractor Southern Star will manage the study at sites across the country.
Strategic alliance: PSI CRO joins forces with Seoul’s Severance Hospital

3 weeks ago | informaconnect.com | Gareth Macdonald

PSI CRO has formed a strategic partnership with Severance Hospital in Seoul, joining the growing list of international contractors building in South Korea by teaming with medical centers. The deal will see PSI manage clinical trials at the hospital. The organizations will collaborate on study feasibility assessments and patient recruitment. Financial terms were not disclosed.
Source Biosciences buys Cambridge Clinical Laboratories to expand clinical offering

3 weeks ago | informaconnect.com | Gareth Macdonald

Source BioScience has acquired Cambridge Clinical Laboratories (CCL), framing the move as a part of an effort to build its trials and diagnostics businesses. The deal will add capabilities in clinical and personalized healthcare testing and a recently built clinical laboratory at the Vision Park campus in Cambridge, UK. Financial details were not disclosed.
Lindus receives UK funding for safe AI trial design optimization project

4 weeks ago | informaconnect.com | Gareth Macdonald

UK R&D agency Advanced Research + Invention Agency (ARIA) awarded Lindus Health funding to develop an artificial intelligence (AI) system for clinical trial design optimization as part of a wider safety program. The project, a collaboration between Lindus and Nobuko Yoshida, a professor at the University of Oxford, aims to develop an AI-based technology that recommends safe and efficient trial designs.